Mike Rockefeller, Co-Chief Investment Officer of Woodline, manager of the Woodline | Spire funds, sits down with executives building tomorrow’s great companies. Candid, strategic conversations. For investors, by an investor. This is inSpired.
inSpired
Claim This Podcastby Woodline Partners
5.0(14 reviews)
2 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇺🇸
Podcast Overview
Mike Rockefeller, Co-Chief Investment Officer of Woodline, manager of the Woodline | Spire funds, sits down with executives building tomorrow’s great companies. Candid, strategic conversations. For investors, by an investor. This is inSpired.
Language
🇺🇲
Publishing Since
4/22/2026
1 verified contact email on file for inSpired
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
June 2, 2026
Dr. Len Schleifer, CEO of Regeneron: Betting on Science and Saving a President
<p>On this episode of inSpired, Mike Rockefeller, Co-Chief Investment Officer of Woodline, sits down with Dr. Leonard Schleifer, Co-Founder, President & CEO of Regeneron, at its headquarters in New York.</p><p> </p><p>Len reflects on the 38-year journey of building Regeneron alongside co-founder Dr. George Yancopoulos, the company's deep pipeline, and the extraordinary story of treating President Trump for COVID-19.</p><p> </p><p>They explore the growth runway for Eyela and Dupixent, its late-stage pipeline spanning obesity, multiple myeloma, anticoagulation, and the C5 franchise, as well as the Regeneron Genetics Center, curing genetic deafness, AI in drug discovery, and the company's disciplined M&A philosophy.</p><p> </p><p>A candid take on science-first drug development and what it takes to succeed in the biotechnology industry going forward.</p><p> </p><p>This is inSpired.</p><p><br>Recorded May 6, 2026.</p><p>_____________________________________________________________________________________________________________________________</p><p>00:00 inSpired with Dr. Leonard Schleifer<br>01:49 Founding Regeneron in 1988<br>08:04 Working with Dr. George Yancopoulos<br>11:44 Top Moments and the EYLEA Approval<br>15:05 Treating President Trump for COVID<br>19:22 EYLEA and EYLEA HD Today<br>20:18 Dupixent and the Type 2 Franchise<br>23:20 Next Generation Immunology<br>29:39 Obesity: A GLP That Lowers Cholesterol<br>33:42 Lynozyfic in Multiple Myeloma<br>34:50 Factor XI Anticoagulation<br>39:46 The C5 Franchise<br>42:48 The Regeneron Genetics Center<br>48:06 Curing Genetic Deafness<br>50:03 AI in Drug Discovery<br>52:17 M&A Philosophy<br>55:47 Succession and Advice for the Next Len</p><p>_____________________________________________________________________________________________________________________________</p><p>Mike Rockefeller is the Co-CIO of Woodline® Partners LP ("Woodline"), manager of the Woodline | Spire funds. All opinions expressed by Mike and podcast guests are solely their own opinions and do not reflect the opinion of Woodline.</p><p>Guests appearing on this podcast may maintain, or may have maintained, business relationships with Woodline or its affiliates. The views expressed by any guest do not constitute an endorsement or testimonial of Woodline.</p><p>This podcast is for educational and informational purposes only, is not directed at any investors or potential investors in any Woodline fund and should not be relied upon as a basis for investment decisions. Funds managed by Woodline, including the Woodline Spire℠ funds, may maintain positions in the securities discussed in this podcast. Any discussion of the past performance of any investment, sector, or market is not indicative of any future results.</p><p><a href="https://woodlinepartners.com/">www.woodlinepartners.com</a></p><p>Be sure to follow us on X/Twitter: <a href="https://x.com/inSpiredPodX">@inSpiredPodX</a></p><p><strong>Episode Credits:</strong><br>Directed by & Artwork Designed by: Brian Thompson / <a href="https://www.btdesignandcreative.com/">BT Design & Creative</a><br>Produced, Edited, and Mixed by: <a href="https://dillonmortensen.com/">Dillon Mortensen Films</a><br>Music Licensed through: Epidemic Sound</p>
April 22, 2026
Dave Ricks, CEO of Eli Lilly: How a 150 Year Old Company Keeps Winning
On this episode of inSpired, Mike Rockefeller, Co-Chief Investment Officer of Woodline, manager of the Woodline | Spire funds, sits down with Dave Ricks, Chair & CEO of Eli Lilly, at its headquarters in Indiana. Ricks dives into the market for GLP-1s, a wide range of potential future applications, and upcoming pipeline drugs like retatrutide and eloralintide. They explore obesity pricing dynamics, Lilly's direct to consumer strategy, drug compounding, and internal vs. external innovation. A sharp, insightful look at science, strategy, and leadership from the CEO who built Eli Lilly into the most valuable healthcare company in the world. This is inSpired. ___________________________________________________________________ Mike Rockefeller is the Co-CIO of Woodline® Partners LP ("Woodline"), manager of the Woodline | Spire funds. All opinions expressed by Mike and podcast guests are solely their own opinions and do not reflect the opinion of Woodline. Guests appearing on this podcast may maintain, or may have maintained, business relationships with Woodline or its affiliates. The views expressed by any guest do not constitute an endorsement or testimonial of Woodline. This podcast is for educational and informational purposes only, is not directed at any investors or potential investors in any Woodline fund and should not be relied upon as a basis for investment decisions. Funds managed by Woodline, including the Woodline Spire℠ funds, may maintain positions in the securities discussed in this podcast. Any discussion of the past performance of any investment, sector, or market is not indicative of any future results.
2 total episodes available
Similar Podcasts
Discover related shows you might enjoy
Invest Like the Best with Patrick O'Shaughnessy
Colossus | Investing & Business Podcasts
Biotech Hangout
Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more
Yet Another Value Podcast
Andrew Walker
Capital Allocators – Inside the Institutional Investment Industry
Ted Seides – Allocator and Asset Management Expert
The Readout Loud
STAT
Business Breakdowns
Colossus | Investing & Business Podcasts
BioCentury This Week
BioCentury
BG2Pod
BG2Pod
a16z Podcast
Andreessen Horowitz
Value Investing with Legends
Columbia Business School
The Long Run with Luke Timmerman
Timmerman Report
All-In with Chamath, Jason, Sacks & Friedberg
All-In Podcast, LLC
No Priors: Artificial Intelligence | Machine Learning | Technology | Startups
Conviction
Dwarkesh Podcast
Dwarkesh Patel
The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
Harry Stebbings
Deep-dive analytics for inSpired
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is inSpired?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.